ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 80 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q3 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $30,897 | -18.1% | 19,432 | -63.0% | 0.00% | 0.0% |
| Q1 2023 | $37,707 | -16.9% | 52,560 | -32.9% | 0.00% | -40.0% |
| Q4 2022 | $45,397 | -40.3% | 78,339 | -2.2% | 0.01% | -16.7% |
| Q3 2022 | $76,000 | -20.8% | 80,079 | 0.0% | 0.01% | -25.0% |
| Q2 2022 | $96,000 | -8.6% | 80,079 | 0.0% | 0.01% | -11.1% |
| Q1 2022 | $105,000 | -52.3% | 80,079 | -35.8% | 0.01% | -52.6% |
| Q4 2021 | $220,000 | -2.2% | 124,795 | +20.4% | 0.02% | -29.6% |
| Q3 2021 | $225,000 | -24.5% | 103,659 | +21.8% | 0.03% | -41.3% |
| Q2 2021 | $298,000 | +60.2% | 85,104 | +350.3% | 0.05% | +12.2% |
| Q1 2021 | $186,000 | -72.5% | 18,901 | -69.7% | 0.04% | -80.7% |
| Q4 2020 | $676,000 | – | 62,344 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 3,915,000 | $5,872,500 | 5.39% |
| Versant Venture Management, LLC | 5,068,233 | $7,602,350 | 4.04% |
| Sonic GP LLC | 2,000,000 | $3,000,000 | 2.91% |
| COMMODORE CAPITAL LP | 10,000,000 | $15,000,000 | 1.75% |
| VR Adviser, LLC | 6,573,300 | $9,859,950 | 1.04% |
| AIGH Capital Management LLC | 1,323,985 | $1,985,977 | 0.94% |
| Newtyn Management, LLC | 1,025,000 | $1,537,500 | 0.38% |
| Worth Venture Partners, LLC | 331,668 | $497,502 | 0.30% |
| Acuitas Investments, LLC | 291,169 | $436,754 | 0.26% |
| Quinn Opportunity Partners LLC | 398,298 | $597,447 | 0.08% |